Hinge Health, Inc. cash flow to debt ratio of 2.13K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Hinge Health, Inc.'s free cash flow has increased 277.49% from $45.23M last year to $170.73M, signaling increasing performance

Hinge Health, Inc.'s debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Hinge Health, Inc.'s debt has decreased relative to shareholder equity from 0.03 last year to 0.02 today, signaling strengthened financials

Hinge Health, Inc. has negative EBITDA, making leverage ratio unreliable

Interest expense is not separately reported in Hinge Health, Inc.'s latest filing, so interest coverage cannot be calculated.

Hinge Health, Inc.'s profit margin has decreased (2.48K%) in the last year from -3.06% to -78.95%, signaling decreasing performance

Hinge Health, Inc.'s short-term assets of $533.90M exceed its short-term liabilities of $362.41M

Hinge Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Hinge Health, Inc.'s return on equity of -138.70%, is lower than 15.00%, indicating bad performance

Hinge Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Hinge Health, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Hinge Health, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Hinge Health, Inc. has a free cash flow yield of 2.47%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Hinge Health, Inc.'s yearly earnings has decreased 4.33K% since last year from $-11.93M to $-528.26M, signaling decreasing performance

Hinge Health, Inc.'s yearly revenue has increased 50.58% since last year from $390.40M to $587.86M, signaling increasing performance

ROIC -165.59% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Hinge Health, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Hinge Health, Inc. had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance

Hinge Health, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Hinge Health, Inc. has insufficient data to evaluate this check.

Hinge Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Hinge Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Hinge Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Hinge Health, Inc. has insufficient data to evaluate this check.

Hinge Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Hinge Health, Inc. has a price-to-book ratio of 22.54x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Hinge Health, Inc. has a price-to-sales ratio of 10.86x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue